Back to Press-Releases
FDA Commissioner Among Top Global Regulators Attending DIA Annual Meeting
Hamburg joins European and Asian regulators to discuss international collaborations and challenges
Food and Drug Administration Commissioner Margaret A. Hamburg and top global regulators from Europe and Japan will tackle the challenges facing international drug and medical device regulators and the impact on therapies and patients at the DIA 2014 50th Annual Meeting in San Diego from June 15 to 19.
Hamburg and global regulators Guido Rasi, executive director of the European Medicines Agency, and Tatsuya Kondo, chief executive of Japan’s Pharmaceutical and Medical Devices Agency, will explore how the model of regulatory collaboration is evolving from traditional harmonization and information-sharing models to strategic coalitions and work-sharing initiatives. The first session in the two-part forum, “New Approaches to International Collaboration Between Regulators,” will be held June 16 from 8:30 to 10 a.m. at the San Diego Convention Center. Part two, featuring regulatory leaders from the U.S., Europe, Brazil, China and Switzerland, will follow at 11 a.m.
Contact: Tiffany Cohen
+1.202.499.4411
Food and Drug Administration Commissioner Margaret A. Hamburg and top global regulators from Europe and Japan will tackle the challenges facing international drug and medical device regulators and the impact on therapies and patients at the DIA 2014 50th Annual Meeting in San Diego from June 15 to 19.
Hamburg and global regulators Guido Rasi, executive director of the European Medicines Agency, and Tatsuya Kondo, chief executive of Japan’s Pharmaceutical and Medical Devices Agency, will explore how the model of regulatory collaboration is evolving from traditional harmonization and information-sharing models to strategic coalitions and work-sharing initiatives. The first session in the two-part forum, “New Approaches to International Collaboration Between Regulators,” will be held June 16 from 8:30 to 10 a.m. at the San Diego Convention Center. Part two, featuring regulatory leaders from the U.S., Europe, Brazil, China and Switzerland, will follow at 11 a.m.
“Dr. Hamburg’s perspective is incredibly valuable to the DIA attendees in understanding the impacts of global regulatory challenges. We are grateful that she and the top international regulatory leaders are lending their voices and expertise to advancing regulatory science and ensuring safe and effective medical products are available to patients worldwide,” said DIA Global Chief Executive Barbara L. Kunz.
Contact: Tiffany Cohen
+1.202.499.4411
###
×
